Literature DB >> 19484871

Current status of end-stage renal disease care in South Asia.

Vivekanand Jha1.   

Abstract

Of the 1.5 million people of South Asia, a large number live in extreme poverty in rural urban areas and have limited access to health care. End-stage renal disease (ESRD) is a devastating medical, social, and economic problem. Lack of registries prevent an accurate assessment of the incidence or prevalence of ESRD, but a recent population-based study assessed the age-adjusted incidence at 232 cases per million population per year. ESRD treatment facilities are available only in major cities, requiring many patients to travel long distances to seek care. Many patients never come to medical attention. Until recently, infection-related glomerulonephritides were considered the most common cause of ESRD, but recent years have shown rapid emergence of diabetic nephropathy as the most frequent cause among new ESRD patients who are younger compared to their Western counterparts. A large number presents with a short history of ESRD of undetermined etiology and often require emergency dialysis. Non-availability of health insurance limits the ability of patients to afford costly ESRD care. The quality of chronic dialysis is dictated mostly by non-medical, financial factors. Maintenance hemodialysis (HD) facilities are scarce. Chronic peritoneal dialysis is not cheaper than HD; high cost and nephrologist bias have limited the growth of peritoneal dialysis in South Asia. Transplants using organs from a related donor is the only viable form of renal replacement therapy for the majority. Cost issues and lack of an effective deceased donor program have limited its availability. Improvement in ESRD care would require strong support from the government, awareness on the part of the medical community of the need of timely referral of these patients to the nephrologist, appropriate pre-dialysis education and development of a network of integrated ESRD treatment facilities for optimal utilization of all forms of renal replacement therapy so that the outcomes of these patients can be improved.

Entities:  

Mesh:

Year:  2009        PMID: 19484871

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  27 in total

1.  Transplantation: the global role of kidney transplantation.

Authors:  Guillermo Garcia Garcia; Paul Harden; Jeremy R Chapman
Journal:  Nat Rev Nephrol       Date:  2012-02-07       Impact factor: 28.314

Review 2.  The Global role of kidney transplantation.

Authors:  Guillermo Garcia Garcia; Paul Harden; Jeremy Chapman
Journal:  J Nephropathol       Date:  2012-07-01

Review 3.  Changes in the worldwide epidemiology of peritoneal dialysis.

Authors:  Philip Kam-Tao Li; Kai Ming Chow; Moniek W M Van de Luijtgaarden; David W Johnson; Kitty J Jager; Rajnish Mehrotra; Sarala Naicker; Roberto Pecoits-Filho; Xue Qing Yu; Norbert Lameire
Journal:  Nat Rev Nephrol       Date:  2016-12-28       Impact factor: 28.314

Review 4.  Maintenance dialysis in developing countries.

Authors:  Aditi Sinha; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2014-01-28       Impact factor: 3.714

5.  The global role of kidney transplantation.

Authors:  G Garcia-Garcia; P Harden; J Chapman
Journal:  Indian J Nephrol       Date:  2012-03

6.  Diabetic nephropathy - Epidemiology in Asia and the current state of treatment.

Authors:  E Ritz; X Zeng
Journal:  Indian J Nephrol       Date:  2011-04

7.  Monthly cost of three exchanges a day peritoneal dialysis is same as of thrice a week hemodialysis in self-paying Indian patients.

Authors:  T K Jeloka; S Upase; S Chitikeshi
Journal:  Indian J Nephrol       Date:  2012-01

8.  Management and outcome of children with end-stage renal disease in northwest Iran.

Authors:  F Mortazavi; M Maleki
Journal:  Indian J Nephrol       Date:  2012-03

9.  Renoprotection and the Bardoxolone Methyl Story - Is This the Right Way Forward? A Novel View of Renoprotection in CKD Trials: A New Classification Scheme for Renoprotective Agents.

Authors:  Macaulay Onuigbo
Journal:  Nephron Extra       Date:  2013-04-27

10.  Timing of nephrology referral: influence on mortality and morbidity in chronic kidney disease.

Authors:  Sushanth Kumar; Jayakumar Jeganathan
Journal:  Nephrourol Mon       Date:  2012-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.